CHONGQING GENRIX BIOPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 688443 for the last quarter is 11.78 M CNY, and it's 1859.46% higher compared to the previous quarter. The net income of Q3 24 is -184.41 M CNY.